CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells
Diane D Mao1, Ryan T Cleary2, Amit Gujar3
1Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Abstract:
Glioblastoma stem cells (GSCs) are an important subpopulation in glioblastoma, implicated in tumor growth, tumor recurrence, and radiation resistance. Understanding the cellular mechanisms for chemo- and radiation resistance could lead to the development of new therapeutic strategies. Here, we demonstrate that CDC20 promotes resistance to chemotherapy and radiation therapy. CDC20 knockdown does not increase TMZ- and radiation-induced DNA damage, or alter DNA damage repair, but rather promotes cell death through accumulation of the pro-apoptotic protein, Bim. Our results identify a CDC20 signaling pathway that regulates chemo- and radiosensitivity in GSCs, with the potential for CDC20-targeted therapeutic strategies in the treatment of glioblastoma.
Insights
CDC20 promotes glioblastoma stem cell resistance to chemotherapy and radiation. Inhibiting CDC20 enhances cell death by increasing the pro-apoptotic protein Bim, offering new therapeutic targets.
Area of Science:
- Oncology
- Cancer Stem Cell Biology
- Molecular Therapeutics
Background:
- Glioblastoma stem cells (GSCs) drive tumor growth, recurrence, and resistance to therapy.
- Understanding resistance mechanisms is crucial for developing effective glioblastoma treatments.
Purpose of the Study:
- To investigate the role of CDC20 in chemo- and radioresistance of glioblastoma stem cells.
- To identify potential therapeutic strategies targeting CDC20 for glioblastoma treatment.
Main Methods:
- CDC20 knockdown experiments in glioblastoma stem cells.
- Assessment of DNA damage and repair.
- Analysis of apoptosis-related protein accumulation, specifically Bim.
Main Results:
- CDC20 knockdown did not alter DNA damage or repair mechanisms.
- CDC20 inhibition led to increased cell death.
- Knockdown of CDC20 resulted in the accumulation of the pro-apoptotic protein Bim.
Conclusions:
- A CDC20 signaling pathway regulates chemo- and radiosensitivity in GSCs.
- Targeting CDC20 presents a potential therapeutic strategy for glioblastoma.
- CDC20 inhibition promotes GSC death via Bim accumulation.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...